Anastasia Lesogor, MD

Accountable for the clinical strategy and functional excellence of a senior team of physicians and scientists, to deliver portfolio and project priorities, across both Cardiovascular and Metabolism therapeutic areas. Develops and executes on the overall clinical strategy supporting clinical design and methodology excellence, biomarker development, quality and compliance and effective dose selection. Responsible for clinical resourcing planning and global talent management to build a leadership and skills pipeline for the future. Ensures seamless transition from the Novartis early development into the full development of early compounds. CVM BD&L activities with evaluation and successful acquisition or in-licensing of early and stage opportunities including full integration into Novartis organization.

HMX Pro Genetics, Certificate of Achievement